06/18/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 6/18/2020. This 44-page report examines the workforce planning for National Disaster Medical System (NDMS) responders to assist with public health emergencies, and training provided to these responders. The Department of Health and Human Services (HHS) responded to COVID-19, in part, by deploying responders enrolled in the NDMS. These individuals, such as doctors and nurses, generally work outside the federal government and are federal employees used intermittently. (PDF)
06/18/2020 12:00 AM EDT
Source: U.S. Senate, Committee on Foreign Relations. Published: 6/18/2020. The witnesses at this Congressional hearing discuss the international response to the COVID-19 pandemic and the future of pandemic preparedness, prevention, and response. Months into the pandemic, important lessons have already been learned that can help to inform future response and ensure that resources continue to be aligned with both national security and international development goals. (Video or Multimedia)
06/18/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 6/18/2020. This web page provides guidance on 16 topics for reducing the risk of transmission of COVID-19 in the hospital setting. (Text)
06/18/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 6/18/2020. This revised guidance concerns use of personal protective equipment (PPE) by health and social care workers, in the context of the current COVID-19 pandemic. It relates solely to considerations of PPE, represents one section of infection prevention and control guidance for COVID-19, and should be used in conjunction with local policies. (Text)
06/18/2020 12:00 AM EDT
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 6/18/2020. This 37-page document describes the value of serosurveys (antibody studies) for SARS-CoV-2 infections, the different methods by which they can be performed, and the resources required to produce actionable information. It provides recommendations for the U.S. government and states for performing these studies and deriving value from them. (PDF)
06/18/2020 12:00 AM EDT
Source: Imperial College London. Published: 6/18/2020. This 29-page report details the 189,403 deaths from any cause reported in England from February 29 to June 5, 2020; 11,278 all-cause deaths in Wales over the same period; and the uncertainty in how many of the non-COVID-19 deaths were directly or indirectly caused by the pandemic. Excess non-COVID-19 deaths could be due to non-reporting of COVID-19 on the death certificate or an increase in mortality for non-COVID-19 conditions. (PDF)
06/18/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 6/18/2020. This web page provides guidance about routes of COVID-19 transmission, infection prevention and control, incubation and infectious period, survival in the environment, and associated legislation. (Text)
06/16/2020 12:00 AM EDT
Source: Network for Public Health Law. Published: 6/16/2020. This 59-page primer, updated on June 16, 2020, provides key information on the public health emergency response to the COVID-19. It includes information about a COVID-19 Epi Snapshot; Emergency Legal Preparedness/Response/Recovery; Public Health Emergency Powers; and Constitutional and Other Challenges. (PDF)
06/16/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 6/16/2020. Throughout the spring of 2020, COVID-19 ravaged the City of New York. State and city authorities worked with the Jacob K. Javits Convention Center to create an alternate care site where healthcare providers could solely treat COVID-19 patients. This nine-page report from TRACIE (Technical Resources, Assistance Center, and Information Exchange) details interviews with several members of the federal medical teams deployed to the Javits Center to learn more about their experience. (PDF)
06/16/2020 12:00 AM EDT
Source: Network for Public Health Law. Published: 6/16/2020. Twenty-four state and local resolutions that address racism as a public health crisis, introduced or adopted since 2019, are included in this five-page assessment. There are common threads of commitment to create accountability for local governments; ensure partnerships with frontline communities that understand the policies that are most beneficial to their communities; revamp workforce development and hiring practices that contribute to health disparities; and prioritize the government’s responsibility to promote anti-racist policies. (PDF)
06/12/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/12/2020. This web page provides guidance for public health and animal health officials and other One Health partners involved in managing companion animals diagnosed with SARS-CoV-2, including those that require hospitalization and those that may be isolated or monitored at home. States or other jurisdictions may have their own specific requirements for these circumstances. (Text)
06/08/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 6/8/2020. This web page provides several guidance documents on the use of personal protective equipment (PPE) for aerosol generating procedures (AGPs) during the COVID-19 pandemic. (Text)
06/05/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/5/2020. This web page outlines the principles for interacting with a person exposed to COVID-19, and provides suggested communication approaches for contact tracers to notify a contact of their exposure, assess their medical condition and other risk factors, and gather information for continued monitoring and support. (Text)
06/05/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/5/2020. This web page provides recommended language to include for a successful COVID-19 case interview, which will allow for the collection of critical information about a person (patient) diagnosed with COVID-19 and potentially exposed contacts, while providing support, referrals, and answers to questions the patient may have. Some language is included in multiple languages. (Text)
06/01/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/2020. This nine-page guidance provides recommendations on statistical considerations to address the impact of COVID-19 on meeting trial objectives for clinical trials conducted during the duration of the COVID-19 public health emergency. It outlines considerations for the statistical analysis of the primary and key secondary endpoints in a trial affected by COVID-19 to help ensure that the trial will provide interpretable findings with correct statistical quantification of uncertainty. (PDF)
06/01/2020 12:00 AM EDT
Source: Network for Public Health Law. Published: 6/2020. This web page provides information and links for a webinar series discussing COVID-19, public and global health law, ethics, vulnerable populations, and calls for social justice. (Video or Multimedia)
06/01/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 6/2020. Following the death of George Floyd in May 2020, protests began in Minneapolis, other cities across the U.S., and abroad. This four-page document summarizes conversations with Dr. John Hick and Seth Jones, Hennepin (MN) Healthcare System’s Emergency Preparedness Program Manager, to better understand how days of civil unrest affected emergency management, the emergency department, emergency medical services, and the community hospitals, and how this factored into the hospital’s COVID-19 response. (PDF)
06/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 6/2020. This 67-page document provides a rapid response guidance checklist to support health care resource allocation decisionmaking during the COVID-19 crisis. The Core Guidance Checklist is intended for use by decisionmakers within health systems, as well as state-level policymakers, to strengthen resource allocation policy development and implementation and improve the decisions that result. (PDF)
05/29/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 5/29/2020. This six-page checklist is a tool that can assist health departments in developing a comprehensive plan for COVID-19 case investigation and contract tracing. The checklist does not describe mandatory requirements or standards; rather, it highlights important areas for consideration. (PDF)
05/28/2020 12:00 AM EDT
Source: Network for Public Health Law. Published: 5/28/2020. This one-hour webinar focuses on emerging constitutional and other legal and policy challenges to state and local efforts to re-open their economies during the COVID-19 pandemic despite concerns of public health officials and health care practitioners over the potential for significant impacts on communal health. (Video or Multimedia)
05/22/2020 12:00 AM EDT
Source: Network for Public Health Law. Published: 5/22/2020. This FAQ provides answers to questions received and addressed in real-time concerning COVID-19 emergency legal preparedness and response in three major categories: Emergency Declarations and Public Health Powers; Social Distancing Powers; and Emerging Issues. (Text)
05/12/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/12/2020. This one-page letter authorizes the emergency use of the Triplex CII-SARS-CoV-2 rRT-PCR Test, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
05/11/2020 12:00 AM EDT
Source: NHS (National Health Service) England. Published: 5/11/2020. This eight-page guidance is focused on supporting compassionate visiting arrangements for those receiving care at the end of life. It provides advice on how visiting at the end of life can be facilitated across a range of settings: Healthcare inpatient settings (including mental health and learning disability); care homes; hospices; and home. (PDF)
05/07/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/7/2020. This one-page letter authorizes the emergency use of the Biocollections Worldwide SARS-CoV-2 Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
05/03/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/3/2020. This one-page letter authorizes the emergency use of the UTHSC/UCH SARS-CoV-2-RT-PCR Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
04/30/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/30/2020. This one-page letter authorizes the emergency use of the Altru Dx SARS-CoV-2 Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
04/28/2020 12:00 AM EDT
Source: NHS (National Health Service) England. Published: 4/28/2020. This 12-page guidance has been requested in order to support clinicians (critical care physicians, anesthetists, nurses, and other support staff) in the safe use of anesthetic machines as ventilation stations for continuous support of COVID-19 patients as part of surge and super-surge capacity. (PDF)
04/28/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/28/2020. This one-page letter authorizes the emergency use of the Biocerna SARS-CoV-2 Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
04/27/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/27/2020. This one-page letter authorizes the emergency use of the Nationwide Children's Hospital SARS-CoV-2 Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
04/24/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/24/2020. This one-page letter authorizes the emergency use of the AIT Laboratories SARS-CoV-2 Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
04/17/2020 12:00 AM EDT
Source: NHS (National Health Service) England. Published: 4/17/2020. This nine-page guidance is aimed at all professionals looking after children and young people with palliative care needs who are infected with COVID-19, potentially entering their end of life phase, and the decision is not for medical escalation into pediatric intensive care. (PDF)
04/14/2020 12:00 AM EDT
Source: University of Oxford. Published: 4/14/2020. The objective of this rapid review was to identify the best available current evidence to support clinicians in responding to COVID-related anxiety, and to provide recommendations for preventing or managing COVID-19 anxiety. (Text)
04/10/2020 12:00 AM EDT
Source: National Health Care for the Homeless Council (HCH). Published: 4/10/2020. This one-hour, two-minute webinar centers around the role of medical respite/recuperative care in the community response to COVID-19. Medical respite providers from Seattle, WA, and Durham, NC, speak to challenges and the roles they’ve played in helping their cities build client-centered quarantine facilities. (Video or Multimedia)
04/08/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 4/8/2020. This web page provides several guidance documents on the use of personal protective equipment (PPE) for non-aerosol generating procedures (APGs) during the COVID-19 pandemic. (Text)
04/01/2020 12:00 AM EDT
Source: National Health Care for the Homeless Council (HCH). Published: 4/2020. This two-page issue brief calls on public health authorities and emergency response systems in every community to conduct more comprehensive COVID-19 testing among people experiencing homelessness, and ensure appropriate follow-up accommodations and support services. (PDF)
02/01/2020 12:00 AM EST
Source: New York Academy of Medicine (NYAM). Published: 2/2020. This 61-page guide was created to help equip New York City-based healthcare providers with tools to facilitate conversations with their patients regarding housing and to link them to appropriate resources. It aims to support providers in assisting patients that are housed, but may be facing housing instability and/or unhealthy housing conditions. (PDF)
.png)
No hay comentarios:
Publicar un comentario